Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Related Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02855658
What this trial is testing

Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
China Medical University Hospital 90
Testing effectiveness (Phase 2)Study completedNCT00046033
What this trial is testing

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 118
Early research (Phase 1)Study completedNCT00077155
What this trial is testing

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+52 more
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT07069439
What this trial is testing

Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire

Who this might be right for
Drug HypersensitivityQuality of Life (QOL)Caregivers+1 more
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization 74
Not applicableNot Yet RecruitingNCT06977594
What this trial is testing

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer
Seoul National University Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT00810602
What this trial is testing

Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

Who this might be right for
Hematologic MalignanciesGraft vs Host Disease
Pavan Reddy, MD 61
Not applicableStudy completedNCT01109745
What this trial is testing

Effectiveness of the Pelican Instrument in Medical Care

Who this might be right for
Asthma
Radboud University Medical Center 120
Testing effectiveness (Phase 2)Looking for participantsNCT00920972
What this trial is testing

Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

Who this might be right for
Metabolic DisordersHematologic, Immune, or Bone Marrow DisordersHemoglobinopathies+1 more
Washington University School of Medicine 220
Not applicableStudy completedNCT01178242
What this trial is testing

Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome.

Who this might be right for
SymblepharonDry EyeOcular Surface Disease+1 more
Federal University of São Paulo 19
Not applicableStudy completedNCT01006005
What this trial is testing

Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens

Who this might be right for
HIV InfectionsAdherence
University of California, San Francisco 51
Not applicableLooking for participantsNCT07680556
What this trial is testing

Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Oncology
Radboud University Medical Center 30
Not applicableLooking for participantsNCT04240522
What this trial is testing

Prospective Longitudinal Observational Research in Atopic Dermatitis

Who this might be right for
Atopic DermatitisAsthmaAtopic Dermatitis and Related Conditions
University of Zurich 1,000
Testing effectiveness (Phase 2)Study completedNCT01775475
What this trial is testing

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

Who this might be right for
AIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell LymphomaAIDS-related Diffuse Small Cleaved Cell Lymphoma+6 more
AIDS Malignancy Consortium 7
Testing effectiveness (Phase 2)Study completedNCT00000803
What this trial is testing

A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 471
Not applicableStudy completedNCT07088770
What this trial is testing

TechMPower: Advancing HIV/SUD Care and Service Delivery for People in Re-entry

Who this might be right for
HIV (Human Immunodeficiency Virus)Substance Abuse Disorder
Columbia University 65
Not applicableStudy completedNCT04028427
What this trial is testing

Impact of ACT-based Interventions on Diabetes-related Outcomes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Sophini Logeswaran 29
Testing effectiveness (Phase 2)Study completedNCT01129401
What this trial is testing

Stonewall Treatment Evaluation Project

Who this might be right for
Substance AbuseHIV Infections
University of California, San Francisco 150
Not applicableStudy completedNCT03063281
What this trial is testing

Anti-ficolin-2 Autoantibodies in Lupus Nephritis

Who this might be right for
Lupus Erythematosus, Systemic
University Hospital, Grenoble 213
Not applicableStudy completedNCT05165953
What this trial is testing

Relationship Between Bronchial Asthma and COVID-19 Infection in Adults: Clinical and Laboratory Assessment

Who this might be right for
AsthmaCOVID-19
Benha University 1,309
Not applicableEnrolling By InvitationNCT06460077
What this trial is testing

Exploring Pathology Related to Slowly Expanding Lesions Using Advanced Imaging

Who this might be right for
Multiple Sclerosis
Turku University Hospital 15
Next Page